TF and neoplasm: Moreover, the dysregulated genes of high-risk patients stratified by TF-9 risk score were found to be enriched in tumor-related signaling pathways such as EMT, angiogenesis, hypoxia, TGF-beta signaling, and platinum drug resistance pathways.